Correlation Between Molina Healthcare and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molina Healthcare and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molina Healthcare and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molina Healthcare and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Molina Healthcare and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molina Healthcare with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molina Healthcare and CRISPR Therapeutics.

Diversification Opportunities for Molina Healthcare and CRISPR Therapeutics

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Molina and CRISPR is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Molina Healthcare and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Molina Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molina Healthcare are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Molina Healthcare i.e., Molina Healthcare and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Molina Healthcare and CRISPR Therapeutics

Considering the 90-day investment horizon Molina Healthcare is expected to generate 0.45 times more return on investment than CRISPR Therapeutics. However, Molina Healthcare is 2.23 times less risky than CRISPR Therapeutics. It trades about 0.05 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.04 per unit of risk. If you would invest  23,573  in Molina Healthcare on August 29, 2022 and sell it today you would earn a total of  9,135  from holding Molina Healthcare or generate 38.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.79%
ValuesDaily Returns

Molina Healthcare  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Molina Healthcare 
Molina Performance
0 of 100
Over the last 90 days Molina Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Molina Healthcare is not utilizing all of its potentials. The new stock price disturbance, may contribute to mid-run losses for the stockholders.

Molina Price Channel

CRISPR Therapeutics 
CRISPR Performance
0 of 100
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2022. The recent disarray may also be a sign of long period up-swing for the firm insiders.

CRISPR Price Channel

Molina Healthcare and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molina Healthcare and CRISPR Therapeutics

The main advantage of trading using opposite Molina Healthcare and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molina Healthcare position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Molina Healthcare vs. Concord Medical Services
Molina Healthcare vs. Community Health Systems
Molina Healthcare vs. Davita Healthcare Partners
Molina Healthcare vs. Hca Holdings
The idea behind Molina Healthcare and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Regeneron Pharmaceuticals
CRISPR Therapeutics vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go